NEWS
Want to find out about what has been happening here at CNH?
Read where we've been in the news below and also catch up on the newsletters that you've missed!
Want to find out about what has been happening here at CNH?
Read where we've been in the news below and also catch up on the newsletters that you've missed!
2021
06 January 2021
The first coronavirus vaccine 'smart patch' is being developed at a Welsh university, researchers say.
The disposable device uses micro-needles to both administer the vaccine and monitor its efficacy by measuring the body's immune response.
A prototype will be developed by the end of March in the hope it can be put forward for clinical trials.
Swansea University researchers aim to make the device commercially available within three years. For more on the story and videos click link to BBC Website
2020
05 November 2020
Four Swansea University projects aimed at making a life-saving difference to patients’ lives have taken a major step forward.
The initiatives, based at Swansea University's Centre for NanoHealth, received funding from the Medical Research Council as part of its 2020 Confidence in Concept (CiC) award. This seeks to take nanomedicine projects from the discovery research stage towards development and the goal of patient benefit. Please click here for full story details.
26 August 2020
Microneedle Skin Patches to Administer Vaccines
A revolutionary new way to give vaccines through microneedle skin patches is being tested at Swansea University, thanks to £200,000 of EU funding announced by the Welsh Government. Please click here to be redirected to full story.
2019
9 January 19
Researchers at CNH, have successfully completed an Innovate UK funded ‘High Efficiency VCSELs Manufacturing” project with strategic semiconductor partners:
The Compound Semiconductor Centre (CSC) and its partners (SPTS Technologies Ltd, an Orbotech company, Cardiff University and Swansea University) are pleased to announce the successful conclusion of an Innovate UK funded project – ‘High Efficiency Manufacturing of Vertical Cavity Surface Emitting Lasers (VCSELs)’
2018
18 July 2018
Smart patches fitted with micro needles to deliver insulin could "revolutionise" treatment for diabetes sufferers.
Scientists in Swansea University (CNH) believe micro needles will change medicinal delivery in various ways, such as being attached to a syringe to administer vaccines.
Prof Owen Guy, director of the Centre of NanoHealth and head of chemistry at Swansea University, said combining the smart patch and the injection would be the ultimate aim. Please click here for more information.
5 June 2018
Finance Secretary Mark Drakeford will today announce a £3.2m initiative to help Welsh businesses pioneer cutting-edge nano and micro technologies.
The scheme, which is led by Swansea University’s Centre for Nano Health and Welsh Centre for Printing and Coating and Cardiff University’s Institute for Compound Semiconductors, will offer expertise and state-of-the-art facilities to companies developing new or existing technologies, products and processes.
Backed by £1.8m of EU funding, it will provide technical and specialist support to put companies at the forefront of innovation in sectors such as healthcare, semiconductors, packaging and functional printed materials. It will also help up to 20 collaborations get underway to develop new products ready for market. Please click here for more information.
13 March 2018
Congratulations to Laura O'Dea (PhD Nanotechnology) on winning the Welsh regional final of FameLab. Laura talked about how we can test the properties of blood to see how likely someone is to suffer from clotting-related diseases (e.g. stroke), and to determine the potential effects of new drugs on blood clotting.
2017
21 November 2017
Huge potential of nanotechnology closer to being unlocked through multi-million pound international project led by the Medical School
Scientists at Swansea University Medical School have just received approval from the European Commission for an international collaborative grant expected to be in excess of €12 million to develop novel cutting-edge tests to prevent the use of animals when assessing safety concerns surrounding nanotechnology.
27 July 2017
CNH PhD Student Olivia Howells Success in KESS 2 Research Image Competition
Congratulations to Olivia Howells a CNH PhD student who won the 'Making Waves' KESS 2 research image competition. Olivia's research is focused on Microneedles, she explains "Transdermal delivery using a hypodermic needle is the routine technique used to administer vaccines. It offers many advantages such as rapid, low-cost administration that avoids first pass metabolism. However, deep penetration through the skin, fat and muscle, stimulates pain, fear and reduces vaccine efficacy. Microneedles being only thousandths of a millimetre in length utilise the depth of the skin by only penetrating the outer layer, this allows a dose-sparing, direct immune response required for vaccination. Microneedles are ideal for patient self-administration as they by-pass nerve stimulation becoming pain-free and do not require extensive training. Thus, my development of these microneedles offers the simplicity of effective, painless vaccinations that can be self-administered from home."
11 July 2017
Huge potential of nanotechnology closer to being unlocked through multi-million-pound international project led by Swansea University
Scientists at Swansea University Medical School have just received approval from the European Commission for an international collaborative grant expected to be in excess of €12million to develop novel cutting-edge tests to prevent the use of animals when assessing safety concerns surrounding nanotechnology.
26 June 2017
Research led by Prof Steve Conlan of the Medical School into the potential medical uses of exosomes with the use of CNH facilities, please click here for more details.
12 June 2017
Sêr Cymru II Fellowships
Congratulations to Dr. Alex Lord, Dr Anitha Devadoss, and Dr Zari Tehrani members of our CNH research staff who have been awarded Sêr Cymru II Fellowships which is Part-funded by the European Regional Development Fund through the Welsh Government. The projects will be focused across various sensor technology platforms.
5 June 2017
Global fight against hepatitis boosted by UK and China research collaboration on new graphene sensor for swifter diagnosis.
Researchers from institutions in China and the UK, including Swansea University, are collaborating on a project to develop a graphene-based sensor, which aims to provide an easy, low-cost way of diagnosing hepatitis on-the-spot.
The two-year, multi-partner project, which is funded by the UK’s Newton Fund and led by Swansea-based BIOVICI, developing the next generation of point-of-care (POC) diagnostic devices, brings together the National Physical Laboratory (NPL), the UK’s National Measurement Institute; the University of Chongqing; Swansea University’s Centre for NanoHealth; and industry partner CTN.
Professor Owen Guy, Director (Engineering) at the Centre for Nanohealth at Swansea University, said: “Using semiconductor process technology applied to graphene enables us to make low-cost sensors. With the right lab-on-chip technology, there is the potential to develop sensors for a host of diagnostic and screening applications”
24 April 2017
The CALIN project is set to push boundaries in the life-science sector following its hugely successful launch events in Ireland and Wales last month. The Irish launch event at Tyndall National Institute showcased a range of expertise including cell biology, nanomedicine, wearable sensor systems and smart implants.
One of the SMEs involved in the CALIN event at Tyndall was Jellagen, a Pembrokeshire based SME who produce collagen products sourced from jellyfish. Jellagen are currently working on a collaborative project with Swansea Universities Centre for Nanohealth and NUI Galway. Andrew Mearns Spragg, CEO of Jellagen, said about the event:
“The CALIN event provided a fantastic platform to network with a range of academic and industrial colleagues. Jellagen is excited to be part of the CALIN project and we look forward to working with our partners to develop robust research into products with real commercial potential”
16 February 2017
Professor Owen Guy, Director of the Centre for NanoHealth (CNH) at Swansea University shares a major €3.5 M grant win from the H2020 Marie Curie Training Network.
As one of the eleven partner institutions led by Plymouth University, a fund of £470,000 is granted for Wales-based research at Swansea Universities CNH.
Professor Guy said “This grant represents a unique opportunity to link with leading European research groups and industry partners, to develop diagnostic technology related to Alzheimer’s disease. The Marie Curie Training Network programme will also deliver a generation of 13 highly-skilled, creative and entrepreneurial Fellows across the network, setting them on a path to successful careers in academia or industry” Please click here for full article.
20 January 2017
New research helps to make the most of nanoscale catalytic effects for nanotechnology
Research scientists at Swansea University are helping to meet the challenge of incorporating nanoscale structures into future semiconductor devices that will create new technologies and impact on all aspects of everyday life. Read more
If you want more information please contact us:
Email: nanohealth@swansea.ac.uk
Fiona John (CNH Administrator) +44 (0) 1792 602985
ILS2, Swansea University, Singleton Park, Swansea, SA2 8PP